Literature DB >> 27374939

Fluid bolus therapy in emergency department patients: Indications and physiological changes.

Shailesh Bihari1,2, David J Teubner3,4, Shivesh Prakash5, Thomas Beatty4, Mark Morphett4, Rinaldo Bellomo6,7,8, Andrew Bersten5,3.   

Abstract

OBJECTIVE: The aim of the present paper is to study the indications for fluid bolus therapy (FBT) and its associated physiological changes in ED patients.
METHODS: Prospective observational study of FBT in a tertiary ED, we recorded indications, number, types and volumes, resuscitation goals and perceived success rates of FBT. Moreover, we studied key physiological variables before, 10 min, 1 h and 2 h after FBT.
RESULTS: We studied 500 FBT episodes (750 [500-1250] mL). Median age was 59 (36-76) years and 57% were male. Shock was deemed present in 135 (27%) patients, septic shock in 80 (16%), and cardiogenic shock in 30 (6%). Overall, 0.9% saline (84%) was the most common fluid and hypotension the most common indication (70%). 'Avoidance of hospital/ICU admission' was the goal perceived to have the greatest success rate (85%). However, although mean arterial pressure (MAP) increased (P < 0.01) and heart rate (HR) decreased (P = 0.04) at 10 min (P = 0.01), both returned to baseline at 1 and 2 h. In contrast, respiratory rate (RR) increased at 1 (P < 0.01) and 2 h (P = 0.03) and temperature decreased at 1 and 2 h (both P < 0.001). In patients with shock, 1 h after FBT, there was a median 3 mmHg increase in MAP (P = 0.01) but no change in HR (P = 0.44), while RR increased (P < 0.01) and temperature decreased (P = 0.01).
CONCLUSIONS: In ED, FBT is used mostly in patients without shock. However, after an immediate haemodynamic effect, FBT is associated with absent or limited physiological changes at 1 or 2 h. Even in shocked patients, the changes in MAP at 1 or 2 h after FBT are small.
© 2016 Australasian College for Emergency Medicine and Australasian Society for Emergency Medicine.

Entities:  

Keywords:  blood pressure; emergency department; fluid bolus; fluid responder; respiratory rate; shock

Mesh:

Year:  2016        PMID: 27374939     DOI: 10.1111/1742-6723.12621

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  7 in total

Review 1.  Personalised fluid resuscitation in the ICU: still a fluid concept?

Authors:  Frank van Haren
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

Review 2.  Fluid Bolus Therapy in Pediatric Sepsis: Current Knowledge and Future Direction.

Authors:  Ben Gelbart
Journal:  Front Pediatr       Date:  2018-10-25       Impact factor: 3.418

Review 3.  The Role of Oliguria and the Absence of Fluid Administration and Balance Information in Illness Severity Scores.

Authors:  Neil J Glassford; Rinaldo Bellomo
Journal:  Korean J Crit Care Med       Date:  2017-05-31

4.  Survey of non-resuscitation fluids administered during septic shock: a multicenter prospective observational study.

Authors:  Anja Lindén-Søndersø; Mårten Jungner; Martin Spångfors; Mohammed Jan; Adam Oscarson; Sally Choi; Thomas Kander; Johan Undén; Donald Griesdale; John Boyd; Peter Bentzer
Journal:  Ann Intensive Care       Date:  2019-11-27       Impact factor: 6.925

5.  The effects of a limited infusion rate of fluid in the early resuscitation of sepsis on glycocalyx shedding measured by plasma syndecan-1: a randomized controlled trial.

Authors:  Jutamas Saoraya; Lipda Wongsamita; Nattachai Srisawat; Khrongwong Musikatavorn
Journal:  J Intensive Care       Date:  2021-01-05

6.  REstricted Fluid REsuscitation in Sepsis-associated Hypotension (REFRESH): study protocol for a pilot randomised controlled trial.

Authors:  Stephen P J Macdonald; David McD Taylor; Gerben Keijzers; Glenn Arendts; Daniel M Fatovich; Frances B Kinnear; Simon G A Brown; Rinaldo Bellomo; Sally Burrows; John F Fraser; Edward Litton; Juan Carlos Ascencio-Lane; Matthew Anstey; David McCutcheon; Lisa Smart; Ioana Vlad; James Winearls; Bradley Wibrow
Journal:  Trials       Date:  2017-08-29       Impact factor: 2.279

7.  Intensive fever control using a therapeutic normothermia protocol in patients with febrile early septic shock: A randomized feasibility trial and exploration of the immunomodulatory effects.

Authors:  Jutamas Saoraya; Khrongwong Musikatavorn; Patima Puttaphaisan; Atthasit Komindr; Nattachai Srisawat
Journal:  SAGE Open Med       Date:  2020-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.